Information for licensed substance use disorder treatment programs

Forms, resources and regulations related to BSAS licensed Alcohol & Drug treatment programs

Substance use disorder treatment program licensing information

If you need information regarding a new license, renewing a license, amending a license, or closing a program, please contact the BSAS Licensing Inspector in your region:

BSAS Licensing Inspector Regions
Central Robin Marin [e-mail] 857-310-0000	Western Gio Vila [e-mail] [phone]
Metro West Nicolette Smith [e-mail] [phone]	Northeast Rachel Brancato [e-mail]
Greater Boston Cassandra Roughan  [e-mail] [phone]	Southeast Michelle Porto [e-mail]
Correctional Facilities Angelica Gates [e-mail] [phone]

Quality Assurance and Licensing Director-
Erica Weil, [e-mail]

Assistant Director of Licensing-
Ryan Walker, [e-mail]

State Opioid Treatment Authority-
Jen Babich, [e-mail]

Assistant Director of Compliance & Investigations-
Sheri Gardner, [e-mail]

If you have any further questions, please contact Sarah Tantillo, Program Coordinator by email at [e-mail]

Reporting Forms

• Health and Safety Required Notification Form (PDF | DOCX)
• Key Personnel Change Form (PDF | DOCX)
• Updates to Notification of Key Personnel Changes to BSAS (PDF | DOCX)
• Death of a Person in Treatment Form (PDF | DOCX)
• Regulatory and Contractual Waiver Request Form (PDF | DOCX)

Regulations

• 105 CMR 164.00 Licensure of Substance Use Treatment Programs
• 105 CMR 168.00 Licensure of Alcohol and Drug Counselors
• For more information and FAQ for POS provider organizations visit: www.mass.gov/hhs/cori
• Federal Regulations 42 CFR Part 2: Confidentiality of Alcohol and Drug Abuse Patient Records

Regulation Guidance

• 105 CMR 164 Guidance- Operational and Licensed Capacity Clarification Memo (PDF l DOCX)
• 105 CMR 164 Guidance - Reorganization and Requirements (PDF | DOCX)
• 105 CMR 164 Guidance - Access to Treatment (PDF | DOCX)
• 105 CMR 164 Guidance - Required Notification (PDF | DOCX)
• 105 CMR 164 Guidance - Safety and Signs of Life Checks (PDF | DOCX)
• 105 CMR 164 Guidance – Supervision (PDF | DOCX)
• 105 CMR 164 Guidance – Staffing (PDF | DOCX)
• 105 CMR 164 Guidance - Special Projects (PDF | DOCX)
• 105 CMR 164 Guidance - Opioid Treatment Program (PDF | DOCX)
• 105 CMR 164 Guidance - Central Registry System (PDF | DOCX)
• 105 CMR 164 Guidance - Commonwealth Agency Licensed and-or Operated Programs (PDF | DOCX)
• 105 CMR 164 Guidance - Penal Facilities (PDF | DOCX)
• 105 CMR 164 - Stakeholder Memo (PDF | DOCX)
• 105 CMR 164 Guidance- Satellites in OP Settings (PDF | DOCX)
• 105 CMR 164- Staffing Grid Guidance (PDF l DOCX)
• 105 CMR 164 Guidance – WMS CSS Flex Programs (PDF l DOCX)
• 105 CMR 164- Clarification of Terminology, Day Treatment Guidance (PDF l DOCX)
• 105 CMR 164 Guidance - Program Closure (PDF) | (DOCX)

Monthly License Program and Bed Reports

Each month the Quality Assurance and Licensing (QAAL) Unit within the Bureau of Substance Addiction Services (BSAS) provides a current report of any substance use disorder treatment programs that hold a license or certificate of approval issued by BSAS. This report shows detailed information on each service tab including program name, organization name, license/approval number, number of licensed beds, main site and other service location(s), medications available, specific populations, address, and BSAS contracted status. The report also shows a summary of main site program counts, bed counts for acute and residential rehabilitation service settings, and an interactive dashboard.

• July 2025 Licensed Programs and Bed Report
• June 2025 Licensed Programs and Bed Report
• May 2025 Licensed Programs and Bed Report

Compliance

If you think your rights around treatment have been violated, please call the BSAS confidential complaint line at [phone]. 

• BSAS Complaint Line Posting (PDF | DOCX)
• BSAS Penal Facility Complaint Form (PDF l DOCX)
• BSAS Spanish Penal Facility Complaint Form (PDF l DOCX)
• BSAS Patient and Resident Rights Posting (PDF | (DOCX)
• Spanish Complaint Line Posting (PDF | DOCX)
• Spanish Patient and Resident Rights Posting (PDF | DOCX)
• Portuguese Complaint Line Posting (PDF | DOCX)
• Portuguese Patient and Resident Rights Posting (PDF | DOCX)
• Ukrainian Complaint Line Posting (PDF | DOCX)
• Ukrainian Patient and Residents Rights Posting (PDF | DOCX)
• Russian Complaint Line Posting (PDF | DOCX)
• Russian Patient and Residents Rights Posting (PDF | DOCX)
• Haitian Creole Complaint Line Posting (PDF | DOCX)
• Haitian Creole Patient and Residents Rights Posting (PDF | DOCX)

Resources

• Information Sheet for Law Enforcement Officials Seeking SUD Treatment Records (PDF l DOCX)
• 42 CFR Part 2 Requirements for Law Enforcement Seeking Patient Information (PDF l DOCX)
• SAMHSA - Improving Access to Evidence-Based Care for Opioid Use Disorder
  • SAMHSA/DEA Webinar – MAT & MATE Act Changes
  • Training Requirements (MATE) Act
  • DEA Registration Training Requirements
• ATS Staffing Grid (PDF | DOCX)
• CSS Staffing Grid (PDF | DOCX)
• Co-Occurring Capable Residential Rehabilitation Service Staffing Grid (PDF | DOCX)
• COE Staffing Grid (PDF | DOCX)
• Medication Specialist Requirements (PDF | DOCX)
• Medication Specialist Template COE RRS (PDF | DOCX)
• Medication Specialist Template TSS (PDF | DOCX)
• TSS Staffing Grid (PDF | DOCX) 

Opioid Treatment Information

• Guidance / Alerts / Memos
  • DPH BSAS Exception Request Guidelines Revised (PDF | DOCX)
  • DPH BSAS Revised Waiver from Certain Regulatory Requirements and Guidance 42 CFR Part 8 and 105 CMR 164.000 (PDF | DOCX)
  • OTP Training and Technical Assistance (OTP TTA) - Regulatory Change Companion Guide (PDF | DOCX)
  • Best Practice Promoting Infectious Disease Testing in MA Opioid Treatment Programs (PDF | DOCX)
  • Central Registry Frequently Asked Questions (PDF | DOCX)
  • BSAS Concurrence With Updated Take-Home Guidance/Criteria (PDF | DOCX)
  • BSAS Concurrence With Physical Evaluation of Patients Who Will Be Treated with Buprenorphine at OTPs (PDF | DOCX)
  • Opioid Treatment Licensing Workflow (PDF | DOCX)
  • Final Rule – BSAS OTP Patient Letter (PDF|DOCX)
  • Final Rule – BSAS OTP Provider Letter (PDF|DOCX)
  • Translated Final Rule Letters
    • Portuguese Final Rule – BSAS OTP Patient Letter (PDF|DOCX)
    • Spanish Final Rule – BSAS OTP Patient Letter (PDF|DOCX)
    • Russian Final Rule – BSAS OTP Patient Letter (PDF|DOCX)
    • Ukrainian Final Rule – BSAS OTP Patient Letter (PDF|DOCX)
    • Haitian Creole Final Rule – BSAS OTP Patient Letter (PDF|DOCX)
    • Vietnamese Final Rule- BSAS OTP Patient Letter (PDF|DOCX)
• Opioid Treatment Resources
  • TIP 63: Medications for Opioid Use Disorder: https://store.samhsa.gov/product/TIP-63-Medications-for-Opioid-Use-Disorder-Full-Document/PEP21-02-01-002
  • SAMHSA Exception Request Submission Instructions: https://www.samhsa.gov/medication-assisted-treatment/otp-resources/submit-exception-request
  • TAP 34: Disaster Planning Handbook for Behavioral Health Service Programs: https://store.samhsa.gov/product/tap-34-disaster-planning-handbook-for-behavioral-health-service-programs/pep21-02-01-001

eLicensing Resources

• BSAS eLicensing Programs User Manual 7.2 (PDF) | (DOCX)
• BSAS eLicensing Training Videos For Programs Completing Applications
  • Tutorial 3 - How to Complete a 24 Hour Diversionary Services Program Application
  • Tutorial 4 – How to Complete an Outpatient Services Program Application
  • Tutorial 5 – How to Complete an Opioid Treatment Program Application
  • Tutorial 6 – How to Complete a Residential Rehabilitation Services Program Application
  • Tutorial 7 – How to Complete a Penal Facility Opioid Treatment Program Application
  • BSAS eLicensing Training Videos For Responding to DCOs
    Tutorial 2 – How to Respond to a Deficiency Correction Order